Jundishapur Journal of Microbiology

Published by: Kowsar

Prevalence of HTLV-I Infection in Patients with Thalassemia Major in Mazandaran, North of Iran

Javad Ghaffari 1 , Mehrnoush Kowsarian 1 , Mohammad Mahdavi 1 , Koroush Vahid Shahi 1 , Houshang Rafatpanah 2 and Amir Tafreshian 2 , *
Authors Information
1 Department of Pediatrics, Mazandaran University of Medical Sciences, Sari, IR Iran
2 Inflammation and Inflammatory Diseases Research Center, School of Medicine, Mashhad University of Medical Sciences, Mashhad, IR Iran
Article information
  • Jundishapur Journal of Microbiology: October 01, 2012, 6 (1); 57-60
  • Published Online: October 24, 2012
  • Article Type: Research Article
  • Received: March 21, 2012
  • Revised: May 7, 2012
  • Accepted: May 15, 2012
  • DOI: 10.5812/jjm.4702

To Cite: Ghaffari J, Kowsarian M, Mahdavi M, Vahid Shahi K, Rafatpanah H, et al. Prevalence of HTLV-I Infection in Patients with Thalassemia Major in Mazandaran, North of Iran, Jundishapur J Microbiol. 2012 ; 6(1):57-60. doi: 10.5812/jjm.4702.

Abstract
Copyright © 2012, Ahvaz Jundishapur University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Gessain A, Barin F, Vernant JC, Gout O, Maurs L, Calender A, et al. Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet. 1985; 2(8452): 407-10[DOI]
  • 2. Hinuma Y, Nagata K, Hanaoka M, Nakai M, Matsumoto T, Kinoshita KI, et al. Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera. Proc Natl Acad Sci U S A. 1981; 78(10): 6476-80[DOI][PubMed]
  • 3. Morofuji-Hirata M, Kajiyama W, Nakashima K, Noguchi A, Hayashi J, Kashiwagi S. Prevalence of antibody to human T-cell lymphotropic virus type I in Okinawa, Japan, after an interval of 9 years. Am J Epidemiol. 1993; 137(1): 43-8[PubMed]
  • 4. Blattner WA, Kalyanaraman VS, Robert-Guroff M, Lister TA, Galton DA, Sarin PS, et al. The human type-C retrovirus, HTLV, in Blacks from the Caribbean region, and relationship to adult Tcell leukemia/lymphoma. Int J Cancer. 1982; 30(3): 257-64[DOI][PubMed]
  • 5. Reeves WC, Saxinger C, Brenes MM, Quiroz E, Clark JW, Hoh MW, et al. Human T-cell lymphotropic virus type I (HTLV-I) seroepidemiology and risk factors in metropolitan Panama. Am J Epidemiol. 1988; 127(3): 532-9[PubMed]
  • 6. Saxinger W, Blattner WA, Levine PH, Clark J, Biggar R, Hoh M, et al. Human T-cell leukemia virus (HTLV-I) antibodies in Africa. Science. 1984; 225(4669): 1473-6[DOI][PubMed]
  • 7. Azarpazjhoo M, Hasanpoor K, Ghanbari M, Rezaee SA, Mashkani B, Hedayati-Moghaddam M, et al. HTLV-I prevalence in Northeastern Iran, Sabzevar; An epidemiologic based study and phylogenetic analysis. AIDS Res Hum Retroviruses. 2012;
  • 8. Farid R, Parizadeh M, Ghaffari J, Miri S, Nassirian A, Rafatpanah H. [Sero-epidemiological evaluation of HTLV-I infection in Neyshabour city]. Mashhad Med Univ J. 2005; 47: 417-24
  • 9. Rafatpanah H, Hedayati-Moghaddam MR, Fathimoghadam F, Bidkhori HR, Shamsian SK, Ahmadi S, et al. High prevalence of HTLV-I infection in Mashhad, Northeast Iran: a population-based seroepidemiology survey. J Clin Virol. 2011; 52(3): 172-6[DOI][PubMed]
  • 10. Karimi A, Nafici M, Imani R. Comparison of Human T-cell Leukemia Virus Type-1 (HTLV-1) Seroprevalence in High Risk Patients (Thalassemia and Hemodialysis) and Healthy Individuals from Charmahal-Bakhtiari Province, Iran. Kuwait Med J. 2007; 39(3): 259
  • 11. Khameneh Z, Baradaran M, Sepehrvand N. Survey of the seroprovalence of HTLV I/II in hemodialysis patients and blood donors in Urmia. Saudi J Kidney Dis Transpl. 2008; 19(5): 838[PubMed]
  • 12. Rafatpanah H, Farid R, Golanbar G, Azad FJ. HTLV-I Infection: virus structure, immune response to the virus and genetic association studies in HTLV-I-infected individuals. Iran J Allergy Asthm. 2006; 5(4)
  • 13. Manns A, Wilks RJ, Murphy EL, Haynes G, Figueroa JP, Barnett M, et al. A prospective study of transmission by transfusion of HTLVI and risk factors associated with seroconversion. Int J Cancer. 1992; 51(6): 886-91[DOI][PubMed]
  • 14. Abolghasemi H, Amid A, Zeinali S, Radfar MH, Eshghi P, Rahiminejad MS, et al. Thalassemia in Iran: epidemiology, prevention,and management. J Pediatr Hematol Oncol. 2007; 29(4): 233-8[DOI][PubMed]
  • 15. Walker J. The heart in thalassemia. Eur Heart J. 2002; 23(2): 102-5[DOI][PubMed]
  • 16. Mansouritorghabeh H, Badiei Z. Transfusion-Transmitted Viruses in Individuals with ß Thalassemia Major at Northeastern Iran,a Retrospective Sero-Epidemiological Survey. Iran J Blood Cancer. 2008; 1(1): 1-4
  • 17. Bangham CR. The immune response to HTLV-I. Curr Opin Immunol. 2000; 12(4): 397-402[DOI]
  • 18. Uchiyama T. Human T cell leukemia virus type I (HTLV-I) and human diseases. Annu Rev Immunol. 1997; 15: 15-37[DOI][PubMed]
  • 19. Chiewsilp P, Iamsilp W, Hathirat P. HTLV-I antibody screening in donated blood and thalassemic patients. J Med Assoc Thai. 1993; 76: 103-5[PubMed]
  • 20. Covas D, Boturão Neto E, Zago M. The frequency of blood-born viral infections in a population of multitransfused Brazilian patients. Rev Inst Med Trop Sao Paulo. 1993; 35(3): 271-3[DOI][PubMed]
  • 21. Ghaffari J, Naghshvar F, Nazari Z, Farid R, Torabizadeh J, Madani F. Seroprevalence of human T-cell lymphotropic virus type 1 infection (HTLV1) in different patients in the north of Iran. Afr J Biotechnol. 2011; 10(52): 10752-5
  • 22. Anaraki M, Sadeghipour A, Vosogh P. Prevalence of HTLV-I in thalassaemic patients receiving continuously blood in Tehran. Med J Iran Uni Med Sci. 2005; 12(47): 19-24
  • 23. Moradi A, Yaghub Nejad Z, Mohagheghi A, Shahraki S, Borgi A, Firouzkouhi M, et al. [Seroepidemiology of HTLV-1 in thalassemia patients from both Zahedan and Zabol in 1380]. Sci J Zanjan Uni Sci. 2003; 43(11): 43-7
  • 24. Pourkarim M, Khamisi G, Hajiani G. [Evaluation of seroepidimiologic of HTLV-I/II in patients who recurrent recipient of blood in Boshehr in 2003]. KHOON. 2005; 2: 99-104
  • 25. Sotoodeh M, Tabei S. Detection of human T-cell leukemia virus carriers in Thalassemia patients in Shiraz: A brief report. Iranian J Med Sci. 1994; 29: 1-2
  • 26. Moradi A, Mansurian A, Ahmadi A, Ghaemi E, Kalavi K, Marjani A, et al. Prevalence of HTLV-1 Antibody among Major Thalassemic Patients in Gorgan (South East of Caspian Sea). J Appl Sci. 2008; 8(2): 391-3[DOI]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments